IO Biotech has declared Chapter 7 bankruptcy and will cease operations, leading to a dramatic 73% drop in its stock price to about $0.046. The decline is viewed as an insolvency event, diverging from broader positive trends in small-cap stocks. Currently, IO Biotech shares are trading significantly below key moving averages, reflecting a bearish trend and heightened selling pressure. Over the past year, the stock has plummeted 96.09%, with no clear support levels established following the sharp sell-off.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.benzinga.com/trading-ideas/movers/26/03/51572463/why-are-shares-of-io-biotech-plummeting
